What If COVID Reinfections Wear Down Our Immunity? | The Tyee
Covid19-Sources
Ralf Wittenbrink on Twitter
Dr Claire Taylor on Twitter
Ralf Wittenbrink on Twitter
OrthopaeDenker on Twitter
Impact of COVID-19 vaccination on long COVID: a systematic review and meta-analysis
Eric Topol auf Twitter
COVID-19 mouth care guidance
Eric Feigl-Ding on Twitter
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
Jan Hartmann on Twitter
Eric Feigl-Ding on Twitter
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Operation Nasal Vaccine—Lightning speed to counter COVID-19
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
Fig. 5: Preterm birth and perinatal mortality after SARS-CoV-2 in pregnancy.a,b, Preterm birth (<37 weeks gestation) rate per 100 live births (a) and extended perinatal mortality rates (b) (stillbirths (death in utero ≥24 weeks gestation) and neonatal deaths within 28 d of birth per 1,000 total births) in different cohorts during the pandemic. Background rate is the rate for all babies born during the pandemic period (1 March 2020 to 31 October 2021); no confirmed SARS-CoV-2 is the rate for babies born during the pandemic period (1 March 2020 to 31 October 2021) to women with no confirmed SARS-CoV-2 infection during pregnancy; any SARS-CoV-2 is the rate for babies born to women who had confirmed SARS-CoV-2 during their pregnancy 1 December 2020 to 31 October 2021; SARS-CoV-2 within 28 d of birth is the rate for babies born to women who had confirmed SARS-CoV-2 during their pregnancy 1 December 2020 to 31 October 2021, restricted to babies born within 28 d of the date of onset of maternal infection; Any COVID-19 vaccination is the rate for babies born to women who had COVID-19 vaccination during their pregnancy 1 December 2020 to 31 October 2021; COVID-19 vaccination within 28 d of birth is the rate for babies born to women who had COVID-19 vaccination during their pregnancy 1 December 2020 to 31 October 2021, restricted to babies born within 28 d of the date of maternal vaccination.
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
Scholar SARS p53
COVID-19 tied to higher risk of stillbirth, maternal death
Ralf Wittenbrink on Twitter
Martin Moder on Twitter
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
DRKS - Deutsches Register Klinischer Studien (German Clinical Trials Register)
How COVID-19 Can Lead to Diabetes
COVID-19 vaccine tracker and landscape
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro - PubMed
In Cleveland and beyond researchers begin to unravel the mystery of long COVID-19